BioLineRx Ltd.

    Jurisdiction
    Israel
    LEI
    529900AKIOSC15Y63R18
    ISIN
    IL0011015182 (BLRX.TA)
    Sectors
    1. Healthcare
    2. Biotechnology

    Scores

    InsiderPie Expert Score
    trending_flat 50 / 100
    Even with peer group:
    50 / 100
    Fair value (Benjamin Graham formula)
    N/A
    Financial strength (Piotroski F-Value)
    4 / 9
    Fundamental strength relative to industry (Mohanram G-Value)
    3 / 7

    Profile

    BioLineRx Ltd., a clinical-stage biopharmaceutical development company, focuses on oncology. Read full profile

    Stock price

    Stock price loading... No stock price available Stock price provided by Lang & Schwarz Steigende Zinsen und niedrigere Bewertungen für Wachstumsaktien im Allgemeinen Eine Gewinnwarnung beim Konkurrenten Adyen signalisiert eine Abkühlung des europäischen Markts für Zahlungsdienstleistungen. Eine Gewinnwarnung von Wordline SA triggert einen massiven Kursverlust.

    Configure chart

    Adjust colors to be more accessible for red-green-colorblind users.
    Scale
    Moving average Display a moving average line on the chart.

    Fundamentals

    Net revenue
    €14.77M
    Gross margin
    59.3%
    EBIT
    -€12.42M
    EBIT margin
    -84.1%
    Net income
    -€6.70M
    Net margin
    -45.3%

    Statement period: - (published )

    Estimates

    Fiscal Year Net revenue Net income
    €5.90M -60.1% -€8.24M +23.1%
    €9.67M +64.0% -€8.21M -0.4%
    €11.73M +21.2% -€11.56M +40.8%

    Dividends

    No dividend payouts

    Earnings Calls

    Latest earnings call: August 14, 2025

    Add to watchlist

    Notifications